Establishes "End-Stage Kidney Disease Prevention and Innovation Act"; appropriates $10 million.
This bill creates the "End-Stage Kidney Disease Prevention and Innovation Act" to establish research centers focused on rare kidney diseases within New Jersey's Department of Health. It allocates $10 million to fund grants and cooperative agreements with public and private nonprofit organizations, prioritizing those that serve underserved and minority communities. The funding supports activities such as conducting medical research, training healthcare providers, developing public awareness materials, and offering fellowships to specialists in nephrology. Additionally, the legislation mandates a study on diagnostic methods and treatment options while ensuring that research evaluations do not discriminate against individuals with disabilities.
Bill status
in committee
1 of 4 stages cleared
Introduction
May 2026
Committee Review
Floor Vote
Governor
Introduced May 14, 2026
Last action May 14, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
May 14, 2026
Introduced
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Benjie Wimberly
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about S 4238
Scope: NJ
Hi! I can help you understand S 4238. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline